Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03622775 · MORE INFO

Limitations, agreements, and source contact

Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant · Source last updated 2026-04-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mqazilba@mdanderson.org
organization
University of Texas MD Anderson Cancer Center
phone
713-745-3459
title
Muzaffar Qazilbash, MD/ Stem Cell Transplantation Department
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
mqazilba@mdanderson.org
organization
University of Texas MD Anderson Cancer Center
phone
713-745-3459
title
Muzaffar Qazilbash, MD/ Stem Cell Transplantation Department

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice